Definium Therapeutics, Inc. (DFTX): Operating Cash Flow
-$131.56M
Year ended 2025-12-31
-$167.95M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$131.56M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$79.13M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$64.36M | n/m | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | -$50.14M | n/m | 2024-02-28, From 2022-01-01 |
| 2021-12-31 | -$45.82M | n/m | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | -$23.60M | n/a | 2022-03-28, From 2020-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | 2025-12-31 | -$131.56M | n/m |
| Jushi Holdings Inc. (JUSH) | 2025-12-31 | $17.73M | -17.8% |
| Glass House Brands Inc. (GLAS) | 2025-12-31 | $11.45M | -59.7% |
| USANA Health Sciences Inc (USNA) | 2026-01-03 | $22.35M | -63.4% |
| Ascend Wellness Holdings, Inc. (AAWH) | 2025-12-31 | $38.05M | -48.1% |
| Marimed Inc. (MRMD) | 2025-12-31 | $7.70M | +13.4% |
| Cronos Group Inc. (CRON) | 2025-12-31 | $25.87M | +37.3% |
| Cresco Labs Inc. (CRLBF) | 2025-12-31 | $72.89M | -45.0% |
| Natural Alternatives International Inc (NAII) | 2026-06-30 | -$8.92M | n/m |
Compare DFTX, JUSH, GLAS, USNA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗